OS THERAPIES INCORPORATED (OSTX) ROA
- 2026-06-30: ROA -397.78%.
- 2026-03-31: ROA -483.25%.
- 2025-12-31: ROA -420.41%.
- 2025-09-30: ROA -204.22%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -397.78% |
| 2026-03-31 | -483.25% |
| 2025-12-31 | -420.41% |
| 2025-09-30 | -204.22% |
| 2025-06-30 | -138.50% |
| 2025-03-31 | -265.91% |
| 2024-12-31 | -160.38% |
| 2024-09-30 | -372.04% |
| 2024-06-30 | -481.00% |
| 2024-03-31 | -705.83% |
| 2023-12-31 | -976.29% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -420.41% |
| 2024-12-31 | -160.38% |
| 2023-12-31 | -976.29% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |